SAPIRSTEIN JAMES — SEC insider filings
SEC reporting owner CIK 1559509. 24 insider filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2021-03-11 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 7 filings — 12,976 shares, $26,498 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 1,887 shares @ $4.96 ($9,360) in Entero Therapeutics, Inc., filed 2024-03-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Entero Therapeutics, Inc. (ENTO) | Chairman and CEO, Director | 11 | — | 7 legs · 12,976 sh · $26,498 | 6 |
| RENOVARO INC. (RENB) | Director | 4 | — | — | 4 |
| Onconetix, Inc. (ONCO) | Director | 3 | — | — | 3 |
| ZyVersa Therapeutics, Inc. (ZVSA) | Director | 2 | — | — | 2 |
| Cocrystal Pharma, Inc. (COCP) | Chief Executive Officer | 1 | — | — | 1 |
| Inmune Bio, Inc. (INMB) | Director | 2 | — | — | 1 |
| MARIZYME INC (MRZM) | Interim CEO, Director | 1 | — | — | 1 |
Insider filings — SAPIRSTEIN JAMES
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Inmune Bio, Inc. (INMB) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-09-16 | 3 | Inmune Bio, Inc. (INMB) | Holdings only — no transactions reported | EDGAR |
| 2026-06-03 | 4 | Cocrystal Pharma, Inc. (COCP) | Grant/award (A): 235,000 (derivative) @ $0 | EDGAR |
| 2025-07-15 | 4 | ZyVersa Therapeutics, Inc. (ZVSA) | Grant/award (A): 11,066 (derivative) @ $0 | EDGAR |
| 2024-09-30 | 4 | Onconetix, Inc. (ONCO) | Grant/award (A): 3,318 @ $0 | EDGAR |
| 2024-07-18 | 4 | ZyVersa Therapeutics, Inc. (ZVSA) | Grant/award (A): 132 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Entero Therapeutics, Inc. (ENTO) | Sale (S): 1,289 @ $1.07 | EDGAR |
| 2024-06-27 | 4 | RENOVARO INC. (RENB) | Grant/award (A): 48,137 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | First Wave BioPharma, Inc. (FWBI) | Sale (S): 174 @ $4.23 | EDGAR |
| 2024-03-19 | 4 | RENOVARO INC. (RENB) | Grant/award (A): 28,196 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | First Wave BioPharma, Inc. (FWBI) | Sale (S): 1,887 @ $4.96 | EDGAR |
| 2024-01-17 | 4 | First Wave BioPharma, Inc. (FWBI) | Sale (S): 166 @ $4.20 | EDGAR |
| 2024-01-03 | 4 | First Wave BioPharma, Inc. (FWBI) | Grant/award (A): 17,660 @ $0 · Grant/award (A): 20,000 @ $0 | EDGAR |
| 2023-10-06 | 4 | First Wave BioPharma, Inc. (FWBI) | Sale (S): 2,764 @ $0.29 | EDGAR |
| 2023-07-05 | 4 | First Wave BioPharma, Inc. (FWBI) | Sale (S): 3,349 @ $1.54 | EDGAR |
| 2023-06-01 | 4 | Blue Water Biotech, Inc. (BWV) | Grant/award (A): 6,360 @ $0 | EDGAR |
| 2023-04-05 | 4 | First Wave BioPharma, Inc. (FWBI) | Sale (S): 3,347 @ $2.50 | EDGAR |
| 2023-04-04 | 4 | Enochian Biosciences Inc (ENOB) | Grant/award (A): 64,655 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | First Wave BioPharma, Inc. (FWBI) | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2022-05-27 | 4 | Blue Water Vaccines Inc. (BWV) | Grant/award (A): 50,575 (derivative) @ $0 | EDGAR |
| 2022-01-03 | 4 | First Wave BioPharma, Inc. (FWBI) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2021-07-02 | 4 | AzurRx BioPharma, Inc. (AZRX) | Other (J): 900,000 (derivative) @ $0 · Grant/award (A): 900,000 (derivative) @ $0 | EDGAR |
| 2021-03-23 | 4 | MARIZYME INC (MRZM) | Grant/award (A): 125,000 (derivative) @ $1.25 | EDGAR |
| 2021-03-11 | 4 | Enochian Biosciences Inc (ENOB) | Grant/award (A): 19,894 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-03-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1559509 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs